Lumicell Co-Founder Moungi Bawendi Awarded Nobel Prize in Chemistry
Lumicell, Inc. , a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced company co-founder Moungi G. Bawendi, PhD, is one of three recipients of the Nobel Prize in Chemistry 2023 for the discovery and synthesis of quantum dots.
- Lumicell, Inc. , a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced company co-founder Moungi G. Bawendi, PhD, is one of three recipients of the Nobel Prize in Chemistry 2023 for the discovery and synthesis of quantum dots.
- The investigational Lumicell Direct Visualization System (DVS), which is designed to assist in the detection of residual cancerous tissue during lumpectomy using fluorescence imaging, was developed in Bawendi’s lab at the Massachusetts Institute of Technology (MIT).
- The New Drug Application (NDA) for the LUMISIGHT™ Optical Imaging Agent and Premarket Approval (PMA) application for the Lumicell™ Direct Visualization System (DVS) are currently under review by the U.S. Food & Drug Administration.
- Images are available for download from the Massachusetts Institute of Technology.